NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $267,411 | -33.6% | 2,650 | -39.5% | 0.03% | -37.8% |
| Q1 2023 | $402,868 | -95.9% | 4,379 | -96.0% | 0.04% | -96.0% |
| Q4 2022 | $9,915,695 | +19.8% | 109,300 | +0.4% | 1.13% | +7.0% |
| Q3 2022 | $8,279,000 | -6.3% | 108,913 | +4.2% | 1.05% | -0.6% |
| Q2 2022 | $8,835,000 | +0.6% | 104,524 | +4.4% | 1.06% | +13.1% |
| Q1 2022 | $8,782,000 | -0.2% | 100,085 | -0.5% | 0.94% | +6.7% |
| Q4 2021 | $8,800,000 | +4.8% | 100,601 | -2.0% | 0.88% | -5.8% |
| Q3 2021 | $8,393,000 | -9.7% | 102,635 | +1.4% | 0.93% | -8.3% |
| Q2 2021 | $9,296,000 | +10.9% | 101,230 | +3.2% | 1.02% | +4.5% |
| Q1 2021 | $8,383,000 | -8.8% | 98,071 | +0.8% | 0.97% | -12.8% |
| Q4 2020 | $9,188,000 | +10.4% | 97,307 | +1.6% | 1.11% | -0.6% |
| Q3 2020 | $8,326,000 | +1.3% | 95,749 | +1.7% | 1.12% | -3.9% |
| Q2 2020 | $8,222,000 | +10.4% | 94,141 | +4.2% | 1.17% | -4.7% |
| Q1 2020 | $7,448,000 | -11.3% | 90,327 | +1.9% | 1.22% | +19.9% |
| Q4 2019 | $8,394,000 | – | 88,654 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |